Britvic plc (LON:BVIC – Get Free Report) shares traded up 14.8% during trading on Friday . The company traded as high as GBX 1,176 ($14.94) and last traded at GBX 1,165 ($14.80). 25,068,539 shares traded hands during mid-day trading, an increase of 3,709% from the average session volume of 658,140 shares. The stock had previously closed at GBX 1,015 ($12.90).
Analyst Upgrades and Downgrades
Several brokerages recently commented on BVIC. Deutsche Bank Aktiengesellschaft initiated coverage on Britvic in a research note on Tuesday, April 30th. They set a “buy” rating and a GBX 1,040 ($13.21) price objective on the stock. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Britvic in a research report on Thursday, May 23rd. Finally, Numis Securities reiterated a “hold” rating and issued a GBX 900 ($11.44) price objective on shares of Britvic in a research report on Thursday, April 11th.
Read Our Latest Stock Report on BVIC
Britvic Stock Performance
Britvic Cuts Dividend
The business also recently announced a dividend, which will be paid on Friday, July 5th. Investors of record on Thursday, May 30th will be issued a dividend of GBX 9.50 ($0.12) per share. The ex-dividend date is Thursday, May 30th. This represents a yield of 1.04%. Britvic’s payout ratio is presently 6,274.51%.
Britvic Company Profile
Britvic plc, together with its subsidiaries, manufactures, markets, distributes, and sells soft drinks in the United Kingdom, the Republic of Ireland, France, Brazil, and internationally. It provides fruit juices, syrups, squash, mineral water, sodas, mixers, and energy and flavored drinks. The company supplies water-coolers and bottled water; offers pension funding and financing services; and designs, installs, as well as engages in maintenance of integrated tap related solutions.
See Also
- Five stocks we like better than Britvic
- What is the S&P 500 and How It is Distinct from Other Indexes
- McDonald’s Stock: Balancing Value and Innovation
- What is the Hang Seng index?
- MarketBeat Week in Review – 6/17 – 6/21
- Health Care Stocks Explained: Why You Might Want to Invest
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Britvic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Britvic and related companies with MarketBeat.com's FREE daily email newsletter.